Abeona Therapeutics (ABEO) Non-Current Assets (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Non-Current Assets of $15.5 million for Q1 2026, up 37.94% year-over-year from $11.2 million in Q1 2025, and up 5.76% quarter-over-quarter from $14.7 million in Q4 2025.
Abeona Therapeutics (ABEO) Non-Current Assets (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $15.5 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 37.94% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $59.1 million (up 67.19% YoY), while the FY2025 annual figure was $14.7 million, up 81.53% from the prior year.
- Non-Current Assets for Q1 2026 stood at $15.5 million, up from $14.7 million in the prior quarter.
- The five-year high for Non-Current Assets was $16.0 million in Q1 2022, with the low at $7.9 million in Q3 2024.
- The 5-year median for Non-Current Assets is $11.1 million (2022), against an average of $11.4 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets slumped 74.05% in 2022, then surged 88.59% in 2025.
- Abeona Therapeutics' Non-Current Assets stood at $11.1 million in 2022, then decreased by 25.64% to $8.3 million in 2023, then dropped by 2.26% to $8.1 million in 2024, then soared by 81.53% to $14.7 million in 2025, then increased by 5.76% to $15.5 million in 2026.
- Business Quant data shows ABEO's Non-Current Assets at $15.5 million in Q1 2026, $14.7 million in Q4 2025, and $15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 14.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.93 Mn |
| Mar 31, 2026 | 15.51 Mn |
| Dec 31, 2025 | 14.66 Mn |
| Sep 30, 2025 | 14.97 Mn |
| Jun 30, 2025 | 13.97 Mn |
| Mar 31, 2025 | 11.24 Mn |
| Dec 31, 2024 | 8.08 Mn |
| Sep 30, 2024 | 7.94 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 8.10 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 8.82 Mn |
| Jun 30, 2023 | 9.51 Mn |
| Mar 31, 2023 | 10.50 Mn |
| Dec 31, 2022 | 11.12 Mn |
| Sep 30, 2022 | 13.26 Mn |
| Jun 30, 2022 | 14.42 Mn |
| Mar 31, 2022 | 15.97 Mn |
| Dec 31, 2021 | 23.29 Mn |
| Sep 30, 2021 | 51.11 Mn |